The precipitate was filtered off, washed with water, and dried. Crystallization from CH OH afforded 6 (2.0 g, 95%), mp 141-
3
-1
+
+
1
[
43°C. IR spectrum (ν, cm ): 3283 (OH), 1651 (C=N), 1634 (C=C). Mass spectrum (m/z): 287 [M] , 270 [M - OH] , 256
M - N - OH]+.
PMR spectrum (δ, ppm, J/Hz): 0.73 (3H, s, CH -18), 0.86 (3H, s, CH -19), 2.45 (1H, d, syn-H-16, J = 3.17), 2.47 (1H,
3
3
d, anti-H-16, J = 8.6), 5.54 (2H, distorted t, H-2, H-3, J = 6.8), 8.01 (1H, s, C=NOH). 13C NMR spectrum (δ, ppm): 11.66
(C-18), 17.09 (C-19), 34.96 (C-16), 126.8 (C-2, C-3), 171.5 (C-17).
1
7β-Formamido-5α-androst-2-ene (8). A mixture of 4 (0.37 g, 1.4 mmol), anhydrous ammonium sulfate (0.04 g,
0
1
.3 mmol), and formic acid (0.14 mL, 3.7 mmol, 99.7%), and formamide (1.3 mL, 38.4 mmol) was heated at 150-160°C for
h and at 180-190°C for 3.5 h, cooled to 20°C, and treated with water (10 mL). After 12 h the precipitate was filtered off,
washed with water, and dried to isolate the product (0.39 g). Chromatography over a column (silica gel L 100/160, eluent
-1
benzene:acetone, 20:1 and 10:1) isolated 8 (0.35 g, 85%), mp 149-151°C. IR spectrum (ν, cm ): 3250 (NH), 1655, 1560
CONH), 1635 (C=C).
7β-Amino-5α-androst-2-ene (5). a) A boiling solution of 6 (3 g, 10.43 mmol) in propan-1-ol (100 mL) was treated
(
1
with portions of metallic sodium (3 g) over 3 h, boiled for 1 h, cooled, and treated with saturated NaCl solution. The organic
layer was evaporated in vacuum to dryness. The solid was dissolved in ether and washed with water until the pH was 7. The
ether extracts were dried (MgSO ). The solvent was evaporated to give the product (2 g). Crystallization from benzene:hexane
4
(1:2) afforded 5 (1.73 g, 60%), mp 145-147°C.
b) A mixture of crude reaction product containing 8 and 9 (0.35 g, 1.2 mmol), aqueous HCl (0.9 mL, 20%), and
CH OH (20 mL) was boiled for 10 h and evaporated in vacuum. The CH OH and solid were heated to dissolve them in water
3
3
(
150 mL). The insoluble precipitate was filtered off. The filtrate was made basic with NaOH until the pH was 8. The resulting
precipitate was filtered off, washed with water, and dried to isolate the product (0.22 g). Crystallization from benzene:hexane
1:2) gave 5 (0.19 g, 59%).
(
-1
+
+
IR spectrum (ν, cm ): 3439 (NH ), 1634 (C C). Mass spectrum (m/z): 273 [M] , 258 [M - NH] .
2
PMR spectrum (δ, ppm, J/Hz): 0.64 (3H, s, CH -18), 0.77 (3H, s, CH -19), 2.64 (1H, t, H-17α, J
= 8.5,
17a /16e
3
3
J17a /16a = 8.8), 5.59 (2H, distorted t, H-2, H-3, J = 6.8). 13C NMR spectrum (δ, ppm): 17.2 (C-18), 20.57 (C-19), 47.9 (C-16),
6
2.0 (C-17), 125.86 (C-2, C-3).
7β-Amino-5α-androstane (1). A solution of 5 (2 g, 7.31 mmol) in absolute EtOH (100 mL) was treated with a
suspension of Pd/C (0.5 g) in EtOH (100 mL) and stirred on a magnetic stirrer under a H atmosphere at 20-25°C until H
1
2
2
absorption stopped. The catalyst was filtered off and washed with hot EtOH. The filtrate was evaporated to dryness. The
resulting oil was triturated in ether and filtered off. Crystallization from benzene:hexane (1:2) isolated 1 (1.51 g, 75%),
mp 89-91°C, lit. [3] mp 86-90°C.
-1
+
+
IR spectrum (ν, cm ): 3439 (NH ). Mass spectrum (m/z): 275 [M] , 260 [M - NH] .
2
PMR spectrum (δ, ppm, J/Hz): 0.61 (3H, s, CH -18), 0.77 (3H, s, CH -19), 2.64 (1H, t, H-17α, J
= 8.5,
17a /16e
3
3
J17a /16a = 8.8).
13C NMR spectrum (δ, ppm): 12.18 (C-18), 20.40 (C-19), 47.08 (C-16), 62.89 (C-17).
REFERENCES
1
2
.
.
T. J. Campbell and E. M. V. Williams, Brit. J. Pharmacol., 76, 337 (1982).
R. A. Lucas, D. F. Dickel, R. L. Dziemian, M. J. Ceglowski, B. L. Hensle, and H. B. McPhillamy, J. Am. Chem.
Soc., 82, No. 21, 5688 (1960).
3
4
5
6
7
8
9
.
.
.
.
.
.
.
J. C. Babcock, U.S. Pat. No. 3,009,925 (1961); Chem. Abstr., 56, P10234f (1962).
R. E. Marker, J. Am. Chem. Soc., 58, 480 (1936).
C. W. Choppe and J. C. P. Sly, J. Chem. Soc., 345 (1959).
J. C. Babcock, U.S. Pat. No. 2,863,885 (1958); Chem. Abstr., 54, P2440f (1960).
E. P. Kemertelidze and T. A. Pkheidze, Khim.-Farm. Zh., 6, No. 12, 44 (1972).
W. H. Kruizinga, B. Strijtveen, and R. M. Kellogg, J. Org. Chem., 46, 4321 (1981).
S. Takasuto and N. Ikekawa, Chem. Pharm. Bull., 23, No. 12, 1431 (1989).
N. Sh. Nadaraia, V. I. Sladkov, L. N. Kuleshova, and N. N. Suvorov, Zh. Org. Khim., 23, No. 3, 533 (1987).
1
1
0.
46